Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
109,968,942
-
Total 13F shares
-
1,949,082
-
Share change
-
+88,387
-
Total reported value
-
$15,421,801
-
Put/Call ratio
-
104%
-
Price per share
-
$7.91
-
Number of holders
-
35
-
Value change
-
+$698,301
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) as of Q2 2023
As of 30 Jun 2023,
Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,949,082 shares.
The largest 10 holders included
Point72 Asset Management, L.P., VANGUARD GROUP INC, Alpine Global Management, LLC, Prentice Capital Management, LP, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc..
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.